Stockscreener 앱 받기
12.53
0.56%
-0.07
시간 외 거래:
12.53
Dr Reddys Laboratories Ltd Adr 주식(RDY)의 최신 뉴스
Antiparasitic Drugs Market Report Released — Examines Antimalarials, Anthelmintics, Antiprotozoals, Ectoparasiticides, and Neglected Tropical Disease Therapies - GlobeNewswire Inc.
ASML Holding N.V. Upgraded, Super Micro Computer Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Price to earnings forward of Dr. Reddy's Laboratories Ltd. Sponsored ADR – MUN:RDDA - TradingView
Korea’s SK Hynix makes history in US – raises $26.5 billion in largest foreign debut - financialexpress.com
SK Hynix plans to price its US listing at $149 - financialexpress.com
Dr Reddy's Shares Slide Over 6% After Semaglutide Batch Quality Concern - NDTV Profit
Dr. Reddy's Labs ADR highlights its global generics footprint as investors track U.S. healthcare dem - ad-hoc-news.de
Dr. Reddy's Labs ADR highlights global generics reach. Investors look at U.S. listing context - Ad-hoc-news.de
RDY News | DR. REDDY'S LABORATORIES-ADR (NYSE:RDY) - ChartMill
Full Transcript: Dr Reddy's Laboratories Q4 2026 Earnings Call - Sahm
Eli Lilly Upgraded, Carvana Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Dr. Reddy’s Laboratories files FY26 annual report with US SEC - scanx.trade
RDDA Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Dr. Reddy's Laboratories Ltd. Sponsored ADR – MUN:RDDA - TradingView
Enterprise value to EBITDA forward of Dr. Reddy's Laboratories Ltd. Sponsored ADR – MUN:RDDA - TradingView
Dr. Reddy's Labs ADR files Form 20-F, shares stay tied to US pharma peers - AD HOC NEWS
Enterprise value to EBIT forward of Dr. Reddy's Laboratories Ltd. Sponsored ADR – MUN:RDDA - TradingView
Dr. Reddy's Laboratories Ltd. ADR Unsponsored Brazilian Depositary Receipt Repr 0.16666667 ADR - TradingView
Dr. Reddy’s files 2026 annual report with the SEC - Stock Titan
659157 Forecast — Price Target — Prediction for 2027 - TradingView
Form 6K DR REDDYS LABORATORIES LTD For: 22 June By Investing.com - Investing.com Nigeria
Form 6K Kinross Gold Corp For: 22 June By Investing.com - Investing.com Nigeria
Dr. Reddy’s (NYSE: RDY) allots 6,730 ESOP shares to employees - Stock Titan
Why Dr. Reddy's Venlafaxine XR capsules quietly matter for everyday patients - Ad-hoc-news.de
Dr. Reddy’s Allots 6,730 ESOP Shares, Expands Issued Capital - TipRanks
Why Dr. Reddy’s Celevida Maxx matters for Indian diabetics - AD HOC NEWS
NIFTY50, SENSEX today: Wall Street cues, FII activity, key things to know before markets open on June 19 - Upstox
Dr. Reddy's Labs (ADR) Stock (US2565981035): Earnings and valuation keep the ADR in focus - ad-hoc-news.de
Dr. Reddy's Laboratories Ltd Stock (INE089A01023): U.S. Bosutinib Launch And Pre-market Drop Put ADR - Ad-hoc-news.de
Dr. Reddy's Laboratories stock (INE089A01023): focus on recent FDA progress and US generics growth - Ad-hoc-news.de
With Lenalidomide Headwinds Behind, Dr. Reddy's Turns to Biosimilars and Consumer Health for Growth - Morningstar
Dr. Reddy’s (NYSE: RDY) allots 12,100 ESOP shares, updates capital - Stock Titan
Dr. Reddy’s Laboratories issues 12,100 equity shares under stock options scheme - Business Upturn
Topicus submits revised $2.00 per share proposal for ReadyTech By Investing.com - Investing.com UK
Topicus submits revised $2.00 per share proposal for ReadyTech - Investing.com UK
RDY - Finviz
Dr. Reddy's Laboratories Ltd ADR (RDY-N) Stock Price and News - The Globe and Mail
Generic Ozempic to hit pharmacies this week, but availability will vary across Canada - The Globe and Mail
Earnings call transcript: Dr. Reddy’s Q4 2026 misses earnings expectations - Investing.com UK
Earnings call transcript: Dr. Reddy’s Q4 2026 misses earnings expectations By Investing.com - Investing.com India
Dr. Reddy's Launches Generic Semaglutide In Canada, Expands GLP-1 Push - Sahm
Dr. Reddy's Laboratories Ltd stock (INE089A01023): earnings miss and dual-market focus draw attentio - AD HOC NEWS
Dr. Reddy's Laboratories stock: Earnings miss shapes outlook - Ad-hoc-news.de
8 Stocks To Buy For Long Term: Analysts recommend 3 largecap, 3 midcap, 2 smallcap scrips; Dr Reddy's Labs on the list - Zee Business
Dr. Reddy’s Labs ADR earnings missed by $0.05, revenue fell short of estimates - Investing.com India
Dr. Reddy's Earnings: Lenalidomide's Slide Digs Into Numbers, but Base Business Remains Solid - Morningstar
Earnings call transcript: Dr. Reddy’s Q4 2026 revenue misses forecast - Investing.com
Earnings call transcript: Dr. Reddy’s Q4 2026 revenue misses forecast By Investing.com - Investing.com Australia
1.90%
1.24%
자본화:
|
볼륨(24시간):